417 related articles for article (PubMed ID: 35014946)
1. Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy.
Xia C; Li Q; Cheng X; Wu T; Gao P; Gu Y
Bioengineered; 2022 Feb; 13(2):2450-2469. PubMed ID: 35014946
[TBL] [Abstract][Full Text] [Related]
2. Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis.
Cheng Z; Jiang S; Tao R; Ge H; Qin J
Bioengineered; 2022 Feb; 13(2):2114-2129. PubMed ID: 35034547
[TBL] [Abstract][Full Text] [Related]
3. LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis.
Yan Z; Bi M; Zhang Q; Song Y; Hong S
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32391554
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway.
Liu Q; Zhang W; Luo L; Han K; Liu R; Wei S; Guo X
Diagn Pathol; 2021 May; 16(1):47. PubMed ID: 34030715
[TBL] [Abstract][Full Text] [Related]
5. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.
Wu EY; Huang LP; Bao JH
Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205
[TBL] [Abstract][Full Text] [Related]
6. LncRNA FTX Promotes Colorectal Cancer Cells Migration and Invasion by miRNA-590-5p/RBPJ Axis.
Chen GQ; Liao ZM; Liu J; Li F; Huang D; Zhou YD
Biochem Genet; 2021 Apr; 59(2):560-573. PubMed ID: 33389283
[TBL] [Abstract][Full Text] [Related]
7. Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement.
Chen H; Li F; Xue Q
Bioengineered; 2022 Feb; 13(2):2828-2840. PubMed ID: 35068326
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA TUG1 promotes cell growth and migration in colorectal cancer via the TUG1-miR-145-5p-TRPC6 pathway.
Wang X; Bai X; Yan Z; Guo X; Zhang Y
Biochem Cell Biol; 2021 Apr; 99(2):249-260. PubMed ID: 32985219
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TUG1 facilitates proliferation, invasion and stemness of ovarian cancer cell via miR-186-5p/ZEB1 axis.
Zhan FL; Chen CF; Yao MZ
Cell Biochem Funct; 2020 Dec; 38(8):1069-1078. PubMed ID: 32390141
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.
Jiang Z; Hou Z; Liu W; Yu Z; Liang Z; Chen S
Bioengineered; 2022 Jan; 13(1):810-823. PubMed ID: 34974791
[TBL] [Abstract][Full Text] [Related]
11. Aloperine inhibits colorectal cancer cell proliferation and metastasis progress via regulating miR-296-5p/STAT3 axis.
Han W; Kong D; Lu Q; Zhang W; Fan Z
Tissue Cell; 2022 Feb; 74():101706. PubMed ID: 34883316
[TBL] [Abstract][Full Text] [Related]
12. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis.
Li C; Gao Y; Li Y; Ding D
Biochem Biophys Res Commun; 2017 Sep; 491(2):552-557. PubMed ID: 28302487
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Long J; Menggen Q; Wuren Q; Shi Q; Pi X
Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
Lu P; Jiang Y; Xia Z
Anticancer Drugs; 2023 Jan; 34(1):144-154. PubMed ID: 36539367
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
16. LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells.
Zheng ZH; You HY; Feng YJ; Zhang ZT
Mol Cell Biochem; 2021 Jul; 476(7):2575-2585. PubMed ID: 32757174
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
18. SNHG14 stimulates cell autophagy to facilitate cisplatin resistance of colorectal cancer by regulating miR-186/ATG14 axis.
Han Y; Zhou S; Wang X; Mao E; Huang L
Biomed Pharmacother; 2020 Jan; 121():109580. PubMed ID: 31704614
[TBL] [Abstract][Full Text] [Related]
19. DICER activates autophagy and promotes cisplatin resistance in non-small cell lung cancer by binding with let-7i-5p.
Li C; Chen L; Song W; Peng B; Zhu J; Fang L
Acta Histochem; 2021 Oct; 123(7):151788. PubMed ID: 34543777
[TBL] [Abstract][Full Text] [Related]
20. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
